|
Abstract Submission
Deadline extended: March 8, 2009
Please submit your abstract
via email as an attachment (with your last name
as the file name) to
ccollard@riverinstitute.ca
in the following format:
FORMAT
All oral and poster presentations require an abstract. We encourage
you to submit and abstract for a special session or general
contributions will be accepted.
PRESENTATIONS
Please note that oral presentations will be limited to 15 minutes,
followed by a 5 minute question/discussion period.
POSTERS
Posters
presenters - posters will be on display throughout the conference
and a special poster session will be held on Wednesday evening.
When submitting:
-
Use your last name for the file name.
-
Abstracts are limited to a maximum of 250 words
-
Please put your
Title
followed by the name of authors
-
Underline the name of the author who will be presenting
-
Indicate
Oral or Poster and
the session you wish to participate in.
-
Make sure your contact information is available with the abstract.
PLEASE WRITE YOUR ABSTRACT FOR A GENERAL
AUDIENCE; ABSTRACTS WILL BE PUBLISHED
AS RECEIVED.
Note:
Authors/ Presenters will be notified of the acceptance of
their papers as soon as possible.
Sample Abstract
Oral Presentation
Session 1
TOXIC EFFECTS OF SELECTED PHARMACEUTICALS EMIITED TO THE ST-LAWRENCE
RIVER FROM A MAHOR MUNICPAL WASTERWATER SOURCE
Blaise, Christian, Pavleta Pavlova, François Gagné,
Robert Tardif, Manon Harwood
Abstract:
Municipal wastewaters are now well-recognized as sources of
“emerging chemicals” comprising diverse household products,
hormonally-active substances and pharmaceuticals. In particular,
effects of the latter class on aquatic biota are poorly understood
at present. Twelve such chemicals were recently detected in the
final effluent of the City of Montreal’s wastewater treatment plant
which treats close to three million cubic meters of combined sewage
and industrial liquid waste per day. To gain a first insight on the
effects they might have on aquatic organisms, their individual and
combined (sub)lethal toxicity was reported via standard measurement
endpoints using laboratory bioassays representative of different
levels of biological organization. Toxicity testing was conducted
with bacteria (Vibrio fischeri light inhibition assay), micro-algae
(Selenastrum capricornutum growth inhibition assay),
micro-crustaceans (Thamnocephalus platyurus lethality assay),
cnidarians (Hydra attenuata sublethality and lethality assay) and
fish cells (rainbow trout hepatocyte cytotoxicity assay).
Additionally, with the cnidarian animal model, Hydra attenuata, a
more subtle sub-lethal endpoint – prey ingestion inhibition – was
also investigated. The relative toxicity of these 12 pharmaceuticals
to bioassay organisms and their potential impact on freshwater
receiving environments will be highlighted during this presentation.
Christian Blaise
Research scientist Centre Saint-Laurent, Environment Canada
105 McGill
Montréal, Que, H2Y 2E7
Telephone:(514)496-7094 Fax:(514)496-7398
Email:christian.blaise@ec.gc.ca
For more information contact:
Christina Collard, Conference Co-ordinator
St. Lawrence River Institute of Environmental Sciences
2 Belmont Street, Cornwall, ON
K6H 4Z1
Tel: 613-936-6620 Ext 222
Fax: 613-936-1803
Email: ccollard@riverinstitute.ca |
